Renal calcium handling in familial hypocalciuric hypercalcemia

Area of Science:

• Nephrology
• Endocrinology
• Human Genetics

Background:

• Familial hypocalciuric hypercalcemia (FHH) is a genetic disorder characterized by hypercalcemia and low urinary calcium excretion.
• Primary hyperparathyroidism (PHP) is a common endocrine disorder that also causes hypercalcemia but typically with higher urinary calcium excretion.
• Differentiating FHH from PHP is crucial for appropriate clinical management.

Purpose of the Study:

• To investigate the differences in calcium and sodium excretion between FHH and PHP.
• To determine the effect of thiazide and loop diuretics on urinary calcium excretion in FHH and PHP.
• To elucidate the specific renal tubular sites of calcium handling abnormalities in FHH.

Main Methods:

• Calcium and sodium excretion rates were measured in FHH and PHP patients.
• Measurements were taken under control conditions and after intravenous administration of chlorothiazide and furosemide.
• Urinary calcium/creatinine ratios were used to assess urinary calcium excretion.

Main Results:

• FHH patients exhibited significantly lower urinary calcium/creatinine ratios than PHP patients under control conditions (0.08 vs. 0.26, P < 0.05).
• Chlorothiazide administration also resulted in lower ratios in FHH compared to PHP (0.14 vs. 0.53, P < 0.01).
• Furosemide infusion abolished the difference in urinary calcium/creatinine ratios between FHH and PHP (1.12 vs. 1.14, P > 0.05).

Conclusions:

• The data suggest enhanced tubular calcium reabsorption in the thick ascending limb of Henle's loop in FHH.
• The site of action for furosemide appears to be involved in the altered calcium handling in FHH.
• An abnormality at a more distal nephron site in FHH cannot be excluded based on these findings.